Search research articles
Contact Us
Filters
Showing results (461-470 of 542) with videos related to
Page
of 55
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)
|
July 28, 2011
Mitochondrial genomics and CD4 T-cell count recovery after antiretroviral therapy initiation in AIDS clinical trials group study 384
Benjamin J Grady, David C Samuels, Gregory K Robbins, et al.
Clinical Pharmacology and Therapeutics
|
November 4, 2000
Steady-state pharmacokinetics of indinavir in cerebrospinal fluid and plasma among adults with human immunodeficiency virus type 1 infection
D W Haas, J Stone, L A Clough, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 2015
Novel dosing strategies increase exposures of the potent antituberculosis drug rifapentine but are poorly tolerated in healthy volunteers
Kelly E Dooley, Radojka M Savic, Jeong-Gun Park, et al.
The Journal of Infectious Diseases
|
January 23, 2024
Prediction Models for Adverse Drug Reactions During Tuberculosis Treatment in Brazil
Felipe Ridolfi, Gustavo Amorim, Lauren S Peetluk, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 6, 2018
Antiretroviral Concentrations in Hair Strongly Predict Virologic Response in a Large Human Immunodeficiency Virus Treatment-naive Clinical Trial
Monica Gandhi, Peter Bacchetti, Igho Ofokotun, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 9, 2011
Translation of HLA-HIV associations to the cellular level: HIV adapts to inflate CD8 T cell responses against Nef and HLA-adapted variant epitopes
Coral-Ann M Almeida, Corine Bronke, Steven G Roberts, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
March 2, 2013
Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012
U Buchholz, M A Müller, A Nitsche, et al.
AIDS (London, England)
|
May 7, 2009
Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment
Richard H Haubrich, Sharon A Riddler, A Gregory DiRienzo, et al.
Pneumologie (Stuttgart, Germany)
|
November 8, 2013
[Recommendations for diagnosis and treatment of nontuberculous mycobacterioses of the German Central Committee against tuberculosis and the German Respiratory Society]
N Schönfeld, W Haas, E Richter, et al.
Antiviral Therapy
|
August 3, 2007
A randomized study of antiviral medication switch at lower- versus higher-switch thresholds: AIDS Clinical Trials Group Study A5115
Sharon A Riddler, Hongyu Jiang, Allan Tenorio, et al.
Page
of 55
Search research articles
Search
Showing results (461-470 of 542) with videos related to
Sort By:
Page
of 55
Journal of Acquired Immune Deficiency Syndromes (1999)
|
July 28, 2011
Mitochondrial genomics and CD4 T-cell count recovery after antiretroviral therapy initiation in AIDS clinical trials group study 384
Benjamin J Grady, David C Samuels, Gregory K Robbins, et al.
Clinical Pharmacology and Therapeutics
|
November 4, 2000
Steady-state pharmacokinetics of indinavir in cerebrospinal fluid and plasma among adults with human immunodeficiency virus type 1 infection
D W Haas, J Stone, L A Clough, et al.
Antimicrobial Agents and Chemotherapy
|
April 1, 2015
Novel dosing strategies increase exposures of the potent antituberculosis drug rifapentine but are poorly tolerated in healthy volunteers
Kelly E Dooley, Radojka M Savic, Jeong-Gun Park, et al.
The Journal of Infectious Diseases
|
January 23, 2024
Prediction Models for Adverse Drug Reactions During Tuberculosis Treatment in Brazil
Felipe Ridolfi, Gustavo Amorim, Lauren S Peetluk, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 6, 2018
Antiretroviral Concentrations in Hair Strongly Predict Virologic Response in a Large Human Immunodeficiency Virus Treatment-naive Clinical Trial
Monica Gandhi, Peter Bacchetti, Igho Ofokotun, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
August 9, 2011
Translation of HLA-HIV associations to the cellular level: HIV adapts to inflate CD8 T cell responses against Nef and HLA-adapted variant epitopes
Coral-Ann M Almeida, Corine Bronke, Steven G Roberts, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin
|
March 2, 2013
Contact investigation of a case of human novel coronavirus infection treated in a German hospital, October-November 2012
U Buchholz, M A Müller, A Nitsche, et al.
AIDS (London, England)
|
May 7, 2009
Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment
Richard H Haubrich, Sharon A Riddler, A Gregory DiRienzo, et al.
Pneumologie (Stuttgart, Germany)
|
November 8, 2013
[Recommendations for diagnosis and treatment of nontuberculous mycobacterioses of the German Central Committee against tuberculosis and the German Respiratory Society]
N Schönfeld, W Haas, E Richter, et al.
Antiviral Therapy
|
August 3, 2007
A randomized study of antiviral medication switch at lower- versus higher-switch thresholds: AIDS Clinical Trials Group Study A5115
Sharon A Riddler, Hongyu Jiang, Allan Tenorio, et al.
Page
of 55